Menlo Therapeutics Inc. (45) | Purchase Agreements (4)
Recent Contracts
-
Securities Purchase Agreement, dated November 11, 2022, between VYNE Therapeutics Inc. and Mutual Fund Series Trust, on behalf of Alpha
(Filed With SEC on November 14, 2022)
-
Purchase Agreement, dated as of March 15, 2022, by and between the Company and Lincoln Park
(Filed With SEC on March 15, 2022)
-
Asset Purchase Agreement, dated as of January 12, 2022, by and between VYNE Therapeutics Inc. and Journey Medical Corporation
(Filed With SEC on January 13, 2022)
-
Form of Securities Purchase Agreement, dated January 26, 2021, among VYNE Therapeutics Inc. and the purchasers identified therein
(Filed With SEC on January 28, 2021)